Your browser is no longer supported. Please, upgrade your browser.
Settings
IRIX IRIDEX Corporation daily Stock Chart
IRIX [NASD]
IRIDEX Corporation
Index- P/E- EPS (ttm)-0.54 Insider Own2.10% Shs Outstand13.79M Perf Week16.18%
Market Cap28.56M Forward P/E- EPS next Y-0.29 Insider Trans6.36% Shs Float11.91M Perf Month18.50%
Income-7.40M PEG- EPS next Q-0.18 Inst Own49.90% Short Float1.36% Perf Quarter44.51%
Sales41.90M P/S0.68 EPS this Y38.80% Inst Trans-0.46% Short Ratio5.32 Perf Half Y-30.70%
Book/sh1.53 P/B1.55 EPS next Y54.20% ROA-25.20% Target Price- Perf Year-15.96%
Cash/sh0.92 P/C2.57 EPS next 5Y30.00% ROE-37.70% 52W Range1.22 - 4.24 Perf YTD6.28%
Dividend- P/FCF- EPS past 5Y-21.60% ROI-39.70% 52W High-44.10% Beta1.13
Dividend %- Quick Ratio2.40 Sales past 5Y0.30% Gross Margin42.00% 52W Low94.26% ATR0.20
Employees94 Current Ratio3.40 Sales Q/Q-15.10% Oper. Margin-21.30% RSI (14)60.72 Volatility16.98% 8.30%
OptionableNo Debt/Eq0.00 EPS Q/Q46.40% Profit Margin-21.00% Rel Volume0.36 Prev Close2.37
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout- Avg Volume30.34K Price2.37
Recom- SMA2011.82% SMA509.65% SMA2007.37% Volume10,896 Change0.00%
Nov-03-17Resumed ROTH Capital Buy
Dec-21-16Initiated ROTH Capital Buy
Jan-26-16Initiated Singular Research Buy $11.50
Jan-03-07Initiated First Albany Buy $15.50
Aug-06-20 04:05PM  
Jul-30-20 12:33PM  
Jul-23-20 04:05PM  
Jun-16-20 03:44AM  
May-16-20 10:05AM  
May-11-20 08:15PM  
04:05PM  
Apr-28-20 05:31PM  
Apr-21-20 08:00AM  
Mar-30-20 04:05PM  
Mar-28-20 12:11AM  
Mar-15-20 09:02AM  
Mar-12-20 06:45PM  
04:05PM  
03:00PM  
Feb-28-20 04:03PM  
Feb-26-20 04:03PM  
Jan-24-20 08:05AM  
Jan-13-20 04:05PM  
Dec-10-19 09:08AM  
Nov-29-19 01:35PM  
Nov-07-19 04:05PM  
Nov-05-19 04:05PM  
Oct-31-19 10:35AM  
Oct-28-19 04:05PM  
Oct-24-19 04:03PM  
03:19PM  
Oct-21-19 10:52AM  
Sep-25-19 10:39AM  
Sep-24-19 02:24PM  
Sep-11-19 05:11PM  
Sep-05-19 06:44PM  
Sep-04-19 12:38PM  
Aug-28-19 09:23AM  
Aug-06-19 06:55PM  
Jul-30-19 10:38AM  
Jul-23-19 04:05PM  
Jul-19-19 11:50AM  
Jul-03-19 09:27PM  
Jun-13-19 10:25AM  
May-21-19 04:03PM  
May-10-19 02:31PM  
May-02-19 08:25PM  
07:17PM  
04:12PM  
Apr-29-19 02:41PM  
08:00AM  
Apr-25-19 10:34AM  
Apr-18-19 04:05PM  
Apr-03-19 03:14PM  
Apr-02-19 06:45PM  
Apr-01-19 12:48PM  
Mar-29-19 06:48PM  
Mar-18-19 04:05PM  
Mar-07-19 02:35AM  
Mar-06-19 08:00AM  
Mar-05-19 04:08PM  
Mar-04-19 08:37AM  
Feb-26-19 08:00AM  
Feb-21-19 10:19AM  
Feb-12-19 08:00AM  
Jan-15-19 10:26AM  
Jan-08-19 04:05PM  
Dec-13-18 10:42AM  
Dec-04-18 04:05PM  
Nov-16-18 08:50AM  
Nov-13-18 10:31AM  
Nov-09-18 03:27PM  
Nov-02-18 07:30AM  
05:03AM  
Nov-01-18 04:05PM  
Oct-25-18 04:05PM  
Oct-23-18 08:00AM  
Oct-18-18 04:05PM  
Oct-15-18 08:00AM  
Sep-17-18 03:02PM  
Sep-14-18 07:00AM  
Sep-13-18 04:01PM  
Sep-06-18 04:05PM  
04:01AM  
Aug-30-18 08:00AM  
Aug-02-18 07:39PM  
04:05PM  
Jul-19-18 04:05PM  
Jul-10-18 08:00AM  
Jun-26-18 09:46AM  
Jun-19-18 08:00AM  
May-08-18 09:55PM  
May-04-18 05:03AM  
May-03-18 04:04PM  
Apr-19-18 04:05PM  
Apr-16-18 04:05PM  
Mar-20-18 03:09PM  
08:00AM  
Mar-10-18 08:06PM  
Mar-08-18 07:09PM  
04:05PM  
02:15PM  
Feb-27-18 04:05PM  
10:38AM  
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, the company offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. It serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. IRIDEX Corporation markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grove Robert EarleDirectorMay 15Buy1.6815,12525,44667,952May 18 06:32 PM
Grove Robert EarleDirectorNov 18Buy2.0414,60029,74952,827Nov 19 04:18 PM
Grove Robert EarleDirectorNov 15Buy2.0210,00020,18738,227Nov 15 07:48 PM
Shuda ScottDirectorNov 14Buy2.0210,00020,20015,000Nov 15 07:37 PM
Shuda ScottDirectorNov 13Buy2.015,00010,0505,000Nov 15 07:37 PM